CovidChloroV1, Main, Exploration, bibRecordById, pubmed:32613227

Reply to Wolowich and Kwon.

Identifieur interne : 000209 ( Main/Exploration ); précédent : 000208; suivant : 000210

Reply to Wolowich and Kwon.

Auteurs : Miao Zhang [République populaire de Chine] ; Xueting Yao [République populaire de Chine] ; Cheng Cui [République populaire de Chine] ; Xu Liu [République populaire de Chine] ; Haiyan Li [République populaire de Chine] ; Dongyang Liu [République populaire de Chine]

Source :

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [ 1537-6591 ] ; 2021.

RBID : pubmed:32613227

Descripteurs français

KwdFr :
- Antiviraux (MeSH), Humains (MeSH), Hydroxychloroquine (MeSH).
MESH :
- Antiviraux, Humains, Hydroxychloroquine.

English descriptors

KwdEn :
- Antiviral Agents (MeSH), COVID-19 (drug therapy), Humans (MeSH), Hydroxychloroquine (MeSH), SARS-CoV-2 (MeSH).
MESH :
- chemical : Antiviral Agents, Hydroxychloroquine.
- drug therapy : COVID-19.
- Humans, SARS-CoV-2.

DOI: 10.1093/cid/ciaa911
PubMed: 32613227
PubMed Central: PMC8096210

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 001250
to stream Main, to step Curation: 001250

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reply to Wolowich and Kwon.</title>
<author><name sortKey="Zhang, Miao" sort="Zhang, Miao" uniqKey="Zhang M" first="Miao" last="Zhang">Miao Zhang</name>
<affiliation wicri:level="3"><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Drug Clinical Trial Center, Peking University Third Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing</wicri:regionArea>
<wicri:noRegion>Nanjing</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yao, Xueting" sort="Yao, Xueting" uniqKey="Yao X" first="Xueting" last="Yao">Xueting Yao</name>
<affiliation wicri:level="3"><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Drug Clinical Trial Center, Peking University Third Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cui, Cheng" sort="Cui, Cheng" uniqKey="Cui C" first="Cheng" last="Cui">Cheng Cui</name>
<affiliation wicri:level="3"><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Drug Clinical Trial Center, Peking University Third Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Liu, Xu" sort="Liu, Xu" uniqKey="Liu X" first="Xu" last="Liu">Xu Liu</name>
<affiliation wicri:level="3"><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Drug Clinical Trial Center, Peking University Third Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Li, Haiyan" sort="Li, Haiyan" uniqKey="Li H" first="Haiyan" last="Li">Haiyan Li</name>
<affiliation wicri:level="3"><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Drug Clinical Trial Center, Peking University Third Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Liu, Dongyang" sort="Liu, Dongyang" uniqKey="Liu D" first="Dongyang" last="Liu">Dongyang Liu</name>
<affiliation wicri:level="3"><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Drug Clinical Trial Center, Peking University Third Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:32613227</idno>
<idno type="pmid">32613227</idno>
<idno type="doi">10.1093/cid/ciaa911</idno>
<idno type="pmc">PMC8096210</idno>
<idno type="wicri:Area/Main/Corpus">001250</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001250</idno>
<idno type="wicri:Area/Main/Curation">001250</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001250</idno>
<idno type="wicri:Area/Main/Exploration">001250</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Reply to Wolowich and Kwon.</title>
<author><name sortKey="Zhang, Miao" sort="Zhang, Miao" uniqKey="Zhang M" first="Miao" last="Zhang">Miao Zhang</name>
<affiliation wicri:level="3"><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Drug Clinical Trial Center, Peking University Third Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing</wicri:regionArea>
<wicri:noRegion>Nanjing</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yao, Xueting" sort="Yao, Xueting" uniqKey="Yao X" first="Xueting" last="Yao">Xueting Yao</name>
<affiliation wicri:level="3"><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Drug Clinical Trial Center, Peking University Third Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cui, Cheng" sort="Cui, Cheng" uniqKey="Cui C" first="Cheng" last="Cui">Cheng Cui</name>
<affiliation wicri:level="3"><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Drug Clinical Trial Center, Peking University Third Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Liu, Xu" sort="Liu, Xu" uniqKey="Liu X" first="Xu" last="Liu">Xu Liu</name>
<affiliation wicri:level="3"><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Drug Clinical Trial Center, Peking University Third Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Li, Haiyan" sort="Li, Haiyan" uniqKey="Li H" first="Haiyan" last="Li">Haiyan Li</name>
<affiliation wicri:level="3"><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Drug Clinical Trial Center, Peking University Third Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Liu, Dongyang" sort="Liu, Dongyang" uniqKey="Liu D" first="Dongyang" last="Liu">Dongyang Liu</name>
<affiliation wicri:level="3"><nlm:affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Drug Clinical Trial Center, Peking University Third Hospital, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</title>
<idno type="eISSN">1537-6591</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (MeSH)</term>
<term>COVID-19 (drug therapy)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antiviraux (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hydroxychloroquine (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Antiviral Agents</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Antiviraux</term>
<term>Humains</term>
<term>Hydroxychloroquine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32613227</PMID>
<DateCompleted><Year>2021</Year>
<Month>05</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>05</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6591</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>72</Volume>
<Issue>9</Issue>
<PubDate><Year>2021</Year>
<Month>05</Month>
<Day>04</Day>
</PubDate>
</JournalIssue>
<Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title>
<ISOAbbreviation>Clin Infect Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Reply to Wolowich and Kwon.</ArticleTitle>
<Pagination><MedlinePgn>1678-1680</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/cid/ciaa911</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>Miao</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yao</LastName>
<ForeName>Xueting</ForeName>
<Initials>X</Initials>
<AffiliationInfo><Affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cui</LastName>
<ForeName>Cheng</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Liu</LastName>
<ForeName>Xu</ForeName>
<Initials>X</Initials>
<AffiliationInfo><Affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Haiyan</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Liu</LastName>
<ForeName>Dongyang</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016420">Comment</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Clin Infect Dis</MedlineTA>
<NlmUniqueID>9203213</NlmUniqueID>
<ISSNLinking>1058-4838</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Clin Infect Dis. 2020 Jul 28;71(15):732-739</RefSource>
<PMID Version="1">32150618</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn"><RefSource>Clin Infect Dis. 2021 May 4;72(9):1677-1678</RefSource>
<PMID Version="1">32607540</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn"><RefSource>Clin Infect Dis. 2021 May 4;72(9):1677-1678</RefSource>
<PMID Version="1">32607540</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>7</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>5</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>7</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32613227</ArticleId>
<ArticleId IdType="pii">5866144</ArticleId>
<ArticleId IdType="doi">10.1093/cid/ciaa911</ArticleId>
<ArticleId IdType="pmc">PMC8096210</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>BMJ. 2020 May 14;369:m1849</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32409561</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Jun 15;369:m2378</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32540958</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Clin Pharmacol. 1988 Sep;26(3):303-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3179169</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Pharmacol Ther. 2020 Aug;108(2):248-252</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32320477</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Cell Biol. 2020 May 18;12(4):322-325</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32236562</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ther Drug Monit. 2016 Apr;38(2):259-67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26587870</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jan 1;1072:320-327</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29207305</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2007 May 03;4:39</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17477867</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2003 Nov;3(11):722-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14592603</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gen Pharmacol. 1982;13(5):433-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7173598</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cell Biol. 1981 Sep;90(3):656-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7287819</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Pharm Sin B. 2020 Jul;10(7):1216-1227</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32834950</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Clin Pharmacol. 1989 Jun;27(6):771-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2757893</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Pharmacol Ther. 2020 Nov;108(5):976-984</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32531808</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pharm Sci. 1983 Nov;72(11):1239-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6644585</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pharmacol Exp Ther. 2018 Jun;365(3):447-459</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29438998</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
<settlement><li>Pékin</li>
</settlement>
</list>
<tree><country name="République populaire de Chine"><noRegion><name sortKey="Zhang, Miao" sort="Zhang, Miao" uniqKey="Zhang M" first="Miao" last="Zhang">Miao Zhang</name>
</noRegion>
<name sortKey="Cui, Cheng" sort="Cui, Cheng" uniqKey="Cui C" first="Cheng" last="Cui">Cheng Cui</name>
<name sortKey="Li, Haiyan" sort="Li, Haiyan" uniqKey="Li H" first="Haiyan" last="Li">Haiyan Li</name>
<name sortKey="Li, Haiyan" sort="Li, Haiyan" uniqKey="Li H" first="Haiyan" last="Li">Haiyan Li</name>
<name sortKey="Liu, Dongyang" sort="Liu, Dongyang" uniqKey="Liu D" first="Dongyang" last="Liu">Dongyang Liu</name>
<name sortKey="Liu, Xu" sort="Liu, Xu" uniqKey="Liu X" first="Xu" last="Liu">Xu Liu</name>
<name sortKey="Yao, Xueting" sort="Yao, Xueting" uniqKey="Yao X" first="Xueting" last="Yao">Xueting Yao</name>
<name sortKey="Zhang, Miao" sort="Zhang, Miao" uniqKey="Zhang M" first="Miao" last="Zhang">Miao Zhang</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000209 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000209 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32613227
   |texte=   Reply to Wolowich and Kwon.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32613227" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Reply to Wolowich and Kwon.

Reply to Wolowich and Kwon.

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki